In healthcare, national averages often hide the real story. What looks like strong market access on paper may not translate into actual product utilization in the field. That’s because local dynamics - payer policies, provider behavior, and reimbursement structures - vary widely across the country.
To navigate this complexity, Precision AQ developed two complementary tools: Local Market Analysis (LMA) and Flow of Funds (FoF). This post explains what they are, how they work, and why they’re useful for teams working in market access, brand strategy, and provider engagement.
LMA is a framework for understanding how payer and provider dynamics influence your brand’s performance at the local level. It helps you move beyond national coverage maps to see:
LMA is especially helpful when you’re seeing unexpected trends, like strong access but low uptake in certain cities, or inconsistent use of your product across regions.
FoF focuses on the economic side of the equation. It analyzes how reimbursement structures, acquisition costs, and provider incentives shape product utilization.
Specifically, it helps you understand:
FoF is useful for identifying the financial levers that affect prescribing behavior, especially when economic incentives are misaligned with your brand's goals.
Understanding how your brand performs across different markets requires more than national-level data. Precision AQ’s LMA and FoF solutions are designed to help you address the specific, often complex challenges that arise when payer policies, provider behavior, and reimbursement structures vary by region.
Here’s how these solutions help you tackle five of the most common and pressing questions brand and market access teams face:
LMA provides a detailed view of your brand’s access status by geography, payer, and provider. It goes beyond published access levels to show where your product is actually being used, where it is being restricted, and how that compares to competitors.
By analyzing control dynamics, LMA helps you understand whether payers or providers are the primary decision-makers in each market. This insight allows you to adjust your strategy, whether that means focusing on contracting, provider engagement, or both.
LMA identifies provider systems that are either aligned with or resistant to your brand’s access position. This helps you prioritize engagement efforts, refine pull-through strategies, and support field teams with data-driven guidance.
Because LMA captures local prescribing behavior and access barriers, it enables you to tailor messaging to the specific needs and realities of each region. This ensures that your communications are relevant and impactful.
FoF reveals how economic factors such as acquisition cost, reimbursement model, and site-of-care economics affect product utilization. These insights help you evaluate whether your pricing and contracting strategies are aligned with market realities and where adjustments may be needed.
Local market dynamics are not just a layer of complexity—they are often the key to understanding why a brand is thriving in one region and struggling in another. Tools like LMA and Flow of Funds help uncover the specific factors that influence access, prescribing behavior, and reimbursement at the local level.
By using these insights, teams can:
If your current strategy relies heavily on national-level assumptions, these solutions offer a way to ground your decisions in the local realities that ultimately shape brand success.
Want to explore how these insights come to life? Schedule a demo: michael.venters@precisionaq.com
You’ll get a guided walkthrough of: